Low-density lipoprotein activates the small GTPases Rap1 and Ral in human platelets

被引:18
作者
Hackeng, CM
Franke, B
Relou, IAM
Gorter, G
Bos, JL
van Rijn, HJM
Akkerman, JWN
机构
[1] Univ Med Ctr Utrecht, Inst Biomembranes, Dept Haematol, NL-3508 GA Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Clin Chem, NL-3508 GA Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Physiol Chem Lab, NL-3508 GA Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Ctr Biomed Genet, NL-3508 GA Utrecht, Netherlands
关键词
GTP; lipid oxidation; lipoproteins; thrombocyte; thromboxane;
D O I
10.1042/0264-6021:3490231
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Physiological concentrations of low-density lipoprotein (LDL) sensitize blood platelets to alpha-thrombin- and collagen-induced secretion, and after prolonged contact trigger secretion independent of other agonists. Here we report that LDL activates the small GTPases Rap1 and Ra1 but not Ras, as assessed by specific precipitation of the GTP-bound enzymes. In unstirred suspensions, the inhibitor SB203580 blocks Rap1 activation by 60-70% suggesting activation via p38 mitogen-activated protein kinase and a second, unidentified route. Inhibitors of cyclooxygenase (indomethacin) and the thromboxane A(2) (TxA(2)) receptor (SQ30741) induce complete inhibition, indicating that Rap1 activation is the result of TxA(2) formation. Stirring reveals a second, TxA(2)-independent Rap1 activation, which correlates quantitatively with a slow induction of dense granule secretion. Both pathways are unaffected by inhibitors of ligand binding to integrin alpha(IIb)beta(3). The results suggest that Rap1 and Ra1, but not Ras, may take part in signalling routes initiated by LDL that initially enhance the sensitivity of platelets to other agonists and later trigger LDL-dependent secretion.
引用
收藏
页码:231 / 238
页数:8
相关论文
共 44 条
[1]   INTRACELLULAR MECHANISMS IN THE ACTIVATION OF HUMAN-PLATELETS BY LOW-DENSITY LIPOPROTEINS [J].
ANDREWS, HE ;
AITKEN, JW ;
HASSALL, DG ;
SKINNER, VO ;
BRUCKDORFER, KR .
BIOCHEMICAL JOURNAL, 1987, 242 (02) :559-564
[2]  
[Anonymous], 1996, Laboratory test handbook
[3]   PLATELET ACTIVATION BY OXIDATIVELY MODIFIED LOW-DENSITY LIPOPROTEINS [J].
ARDLIE, NG ;
SELLEY, ML ;
SIMONS, LA .
ATHEROSCLEROSIS, 1989, 76 (2-3) :117-124
[4]   LOW-DENSITY LIPOPROTEIN BINDING TO HUMAN-PLATELETS - ROLE OF CHARGE AND OF SPECIFIC AMINO-ACIDS [J].
AVIRAM, M ;
BROOK, JG ;
LEES, AM ;
LEES, RS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 99 (01) :308-318
[5]   IDENTIFICATION OF MULTIPLE RAL GENE-PRODUCTS IN HUMAN PLATELETS THAT ACCOUNT FOR SOME BUT NOT ALL OF THE PLATELET GN-PROTEINS [J].
BHULLAR, RP ;
CHARDIN, P ;
HASLAM, RJ .
FEBS LETTERS, 1990, 260 (01) :48-52
[6]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[7]   Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells [J].
Börsch-Haubold, AG ;
Bartoli, F ;
Asselin, J ;
Dudler, T ;
Kramer, RM ;
Apitz-Castro, R ;
Watson, SP ;
Gelb, MH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (08) :4449-4458
[8]   Phosphorylation and activation of cytosolic phospholipase A(2) by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets [J].
BorschHaubold, AG ;
Kramer, RM ;
Watson, SP .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 245 (03) :751-759
[9]   CYTOSOLIC PHOSPHOLIPASE A(2) IS PHOSPHORYLATED IN COLLAGEN-STIMULATED AND THROMBIN-STIMULATED HUMAN PLATELETS INDEPENDENT OF PROTEIN-KINASE-C AND MITOGEN-ACTIVATED PROTEIN-KINASE [J].
BORSCHHAUBOLD, AG ;
KRAMER, RM ;
WATSON, SP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (43) :25885-25892
[10]   The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs) [J].
Clerk, A ;
Sugden, PH .
FEBS LETTERS, 1998, 426 (01) :93-96